Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)

SHA:600645 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,120	1,525	1,581	1,393	1,196	1,060
Trading Asset Securities	543.18	-	-	-	-	-
Cash & Short-Term Investments	1,663	1,525	1,581	1,393	1,196	1,060
Cash Growth	15.64%	-3.56%	13.48%	16.54%	12.76%	2.61%
Accounts Receivable	637.85	644.94	610.53	575.98	510.95	512.64
Other Receivables	15.76	11.6	18.09	28.41	16.58	28.24
Receivables	653.61	656.54	628.62	604.39	527.53	540.88
Inventory	237.24	232.19	247.9	248.09	226.96	222.4
Prepaid Expenses	-	0.51	2.38	6.48	2.98	-
Other Current Assets	41.92	42.08	48.36	57.64	77.08	91.51
Total Current Assets	2,596	2,456	2,508	2,310	2,030	1,915
Property, Plant & Equipment	641.82	688.71	705.33	765.54	766.09	733.46
Long-Term Investments	745.68	736.84	779.96	804.31	886.53	872.49
Goodwill	702.91	702.91	702.91	702.91	702.91	722.63
Other Intangible Assets	89.38	100.45	101.42	111.73	133.96	147.95
Long-Term Accounts Receivable	20.74	28.47	37.45	52	65.9	68.95
Long-Term Deferred Tax Assets	91.79	92.95	81.8	56.02	46.94	47.83
Long-Term Deferred Charges	160.07	165.22	159.98	148.88	141.13	130.63
Other Long-Term Assets	268.81	277.08	334	333.2	259.72	240.52
Total Assets	5,317	5,249	5,411	5,285	5,033	4,880
Accounts Payable	121.06	47.32	68.76	56.85	32.12	43.21
Accrued Expenses	70.86	170.15	146.96	134.91	132.33	120.21
Current Portion of Long-Term Debt	-	-	6.31	6.31	6.31	9.34
Current Portion of Leases	21.12	43.75	23.34	21.19	16.69	-
Current Income Taxes Payable	35.31	6.71	17.93	30.38	24.97	20.99
Current Unearned Revenue	1,129	1,134	1,137	1,112	1,078	1,024
Other Current Liabilities	93.69	85.4	81.29	109.64	105.56	82.41
Total Current Liabilities	1,471	1,487	1,482	1,471	1,396	1,300
Long-Term Debt	-	-	9.46	15.77	22.08	37.53
Long-Term Leases	51.53	80	88.37	97.9	37.11	11.6
Long-Term Unearned Revenue	9.68	9.56	10.02	10.92	11.08	13.64
Long-Term Deferred Tax Liabilities	11.69	12.95	23.15	34.87	34.7	14.41
Other Long-Term Liabilities	11.6	-	-	-	-	-
Total Liabilities	1,556	1,590	1,613	1,631	1,501	1,377
Common Stock	467.95	467.95	467.95	467.95	467.95	467.95
Additional Paid-In Capital	3,390	3,374	3,377	3,384	3,383	3,378
Retained Earnings	-86.02	-193.92	-294.27	-400.73	-513.71	-687.7
Treasury Stock	-200.03	-200.03	-	-	-	-
Comprehensive Income & Other	139.33	147.54	133.31	104.7	125.98	238.53
Total Common Equity	3,711	3,595	3,684	3,556	3,463	3,396
Minority Interest	50.5	63.98	114.55	97.85	69.31	106.03
Shareholders' Equity	3,762	3,659	3,799	3,654	3,533	3,502
Total Liabilities & Equity	5,317	5,249	5,411	5,285	5,033	4,880
Total Debt	72.65	123.75	127.48	141.18	82.2	58.48
Net Cash (Debt)	1,591	1,401	1,454	1,252	1,113	1,002
Net Cash Growth	21.02%	-3.61%	16.09%	12.46%	11.14%	11.58%
Net Cash Per Share	3.55	3.07	3.14	2.66	2.37	2.13
Filing Date Shares Outstanding	455.9	455.9	467.95	467.95	467.95	467.95
Total Common Shares Outstanding	455.9	455.9	467.95	467.95	467.95	467.95
Working Capital	1,125	968.93	1,027	838.53	634.56	615.09
Book Value Per Share	8.14	7.89	7.87	7.60	7.40	7.26
Tangible Book Value	2,919	2,792	2,880	2,741	2,627	2,526
Tangible Book Value Per Share	6.40	6.12	6.15	5.86	5.61	5.40
Land	-	3.54	3.49	3.43	3.14	3.21
Buildings	-	546.68	482.6	497.7	558.38	560.89
Machinery	-	700.82	690.88	653.02	623.86	583.77
Construction In Progress	-	10.54	18.98	23.23	20.5	8.06

Source: S&P Global Market Intelligence. Standard template. Financial Sources.